![Brian Mooney](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Brian Mooney
Chief Operating Officer at ProSciento, Inc.
Profile
Brian Mooney is currently the Chief Operating Officer at ProSciento, Inc. Prior to this, he worked as the Director-Project Management at Pharmaceutical Research Associates, Inc., Program Director at Covance Clinical & Periapproval Services SRL, and Senior Vice President-Global Clinical Development at Theorem Clinical Research, Inc. He completed his undergraduate degree from Notre Dame High School Trenton NJ, Inc.
Brian Mooney active positions
Companies | Position | Start |
---|---|---|
ProSciento, Inc.
![]() ProSciento, Inc. Miscellaneous Commercial ServicesCommercial Services ProSciento, Inc. is a full-service clinical research organization that works with biopharma companies worldwide to support their outsourced clinical research needs. The company is based in Chula Vista, CA, and has subsidiaries in the United States. The company specializes in providing comprehensive and customized services for multinational, early development clinical trial programs for metabolic continuum diseases, including diabetes, obesity, and steatotic liver disease. ProSciento has conducted over 300 clinical projects and supported the development of many approved metabolic drugs and devices on the market. ProSciento was founded in 2003, and Marcus Hompesch has been the CEO of the company since its inception. | Chief Operating Officer | - |
Former positions of Brian Mooney
Companies | Position | End |
---|---|---|
Pharmaceutical Research Associates, Inc.
![]() Pharmaceutical Research Associates, Inc. Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Research Associates, Inc. engages in the provision of clinical research services. It focuses on therapeutic, global regulatory affairs, and pharmacovigilance and patient safety. The company was founded in 1982 and is headquartered in Raleigh, NC. | Corporate Officer/Principal | - |
Covance Clinical & Periapproval Services SRL | Corporate Officer/Principal | - |
Theorem Clinical Research, Inc.
![]() Theorem Clinical Research, Inc. Medical/Nursing ServicesHealth Services Theorem Clinical Research, Inc. is a contract research organization that provides core clinical research and development services. The company was founded in 1985 and is headquartered in King of Prussia, PA. | Corporate Officer/Principal | - |
Training of Brian Mooney
Notre Dame High School Trenton NJ, Inc. | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
Pharmaceutical Research Associates, Inc.
![]() Pharmaceutical Research Associates, Inc. Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Research Associates, Inc. engages in the provision of clinical research services. It focuses on therapeutic, global regulatory affairs, and pharmacovigilance and patient safety. The company was founded in 1982 and is headquartered in Raleigh, NC. | Commercial Services |
Theorem Clinical Research, Inc.
![]() Theorem Clinical Research, Inc. Medical/Nursing ServicesHealth Services Theorem Clinical Research, Inc. is a contract research organization that provides core clinical research and development services. The company was founded in 1985 and is headquartered in King of Prussia, PA. | Health Services |
Covance Clinical & Periapproval Services SRL | |
ProSciento, Inc.
![]() ProSciento, Inc. Miscellaneous Commercial ServicesCommercial Services ProSciento, Inc. is a full-service clinical research organization that works with biopharma companies worldwide to support their outsourced clinical research needs. The company is based in Chula Vista, CA, and has subsidiaries in the United States. The company specializes in providing comprehensive and customized services for multinational, early development clinical trial programs for metabolic continuum diseases, including diabetes, obesity, and steatotic liver disease. ProSciento has conducted over 300 clinical projects and supported the development of many approved metabolic drugs and devices on the market. ProSciento was founded in 2003, and Marcus Hompesch has been the CEO of the company since its inception. | Commercial Services |
- Stock Market
- Insiders
- Brian Mooney